早产儿视网膜筛查的护理配合及散瞳效果

发布时间：2018-01-27 06:25

本文关键词： 散瞳早产儿视网膜病变筛查护理复方托吡卡胺　出处：《实用医学杂志》2017年09期 　论文类型：期刊论文

【摘要】：目的:探讨早产儿视网膜筛查的护理配合及影响散瞳效果的相关因素。方法:前瞻性分析132例在我院进行视网膜筛查的早产儿,使用复方托吡卡胺散瞳,每次1滴,每5分钟滴药1次,右眼共滴药3次,左眼共滴药5次,末次滴药后30 min记录瞳孔直径,对结果进行统计学分析,观察矫正胎龄和滴药次数对散瞳效果的影响,并总结检查前后的护理注意事项。结果:其中128例受检儿瞳孔散大满意,4例瞳孔散大不满意。散瞳效果与矫正胎龄无明显相关(P0.05);3次滴药即可使绝大部分受检儿瞳孔散大满意。结论:散瞳前后的护理及生命体征的观察是受检患儿安全的重要保证;绝大部分受检儿、仅需以复方托吡卡胺滴眼3次即可达到满意散瞳要求。
[Abstract]:Objective: to explore the nursing cooperation of retinal screening of premature infants and the related factors affecting the effect of mydriasis. Methods: 132 cases of premature infants who underwent retinal screening in our hospital were treated with compound topiramine for mydriasis. The pupillary diameter was recorded 30 min after the last drop. The results were statistically analyzed. To observe the effect of corrected gestational age and the number of drops on the effect of pupil dilation, and summarize the nursing matters needing attention before and after examination. Results: 128 cases were satisfied with pupil dilatation. 4 cases were not satisfied with pupil dilation. There was no significant correlation between the effect of pupil dilation and corrected gestational age (P0.05). Conclusion: the nursing before and after pupil dilation and the observation of vital signs are the important guarantee for the safety of the tested children. In most of the tested children, the eye drops of compound topiramine can meet the requirements of mydriasis.
【作者单位】：广州市妇女儿童医疗中心眼科;
【基金】：广东省科技公益研究与能力建设项目(编号:20140212)
【分类号】：R472
【正文快照】： 早产儿视网膜病变(retinopathy of premacuri-ty,ROP)是一类发生于早产儿和低体重儿的血管增生性玻璃体视网膜疾病,为儿童致盲的常见眼病。我国自2004年《早产儿治疗用氧和视网膜病变防治指南》[1]颁布以来,ROP的筛查工作已经在全国各地广泛开展。检查前瞳孔充分散大是保证ROP

【相似文献】